New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
DIFFERENCES IN PLATELET MONO-AMINE OXIDASE ACTIVITY IN SUBGROUPS OF SCHIZOPHRENIC AND DEPRESSIVE-DISORDERS
ÌÇÐÄ´«Ã½
DIFFERENCES IN PLATELET MONO-AMINE OXIDASE ACTIVITY IN SUBGROUPS OF SCHIZOPHRENIC AND DEPRESSIVE-DISORDERS BIOLOGICAL PSYCHIATRY Orsulak, P. J., Schildkraut, J. J., Schatzberg, A. F., HERZOG, J. M. 1978; 13 (6): 637-647Abstract
Platelet monoamine oxidase (MAO) activity was measured in patients with nonaffective schizophrenic disorders (i.e., without prominent symptoms of depressions or manias), and in patients with schizophrenia-related depressions. MAO activity was significantly lower than control values in a subgroup of 16 patients with nonaffective schizophrenic disorders (most of whom were paranoid) characterized by the presence of auditory hallucinations and delusions. Platelet MAO activity was not reduced in 16 other nonaffective schizophrenic patients without auditory hallucinations. Platelet MAO activity was significantly higher than control values in a group of 8 depressed patients with schizophrenia-related depressions characterized by the presence of chronic asocial, eccentric, or bizarre behavior. These findings of differences in platelet MAO activity in clinically defined subgroups of nonaffective schizophrenic disorders and the schizophrenia-related depressive disorders may help to account for some of the discrepancies in findings among the various studies of platelet MAO activity in schizophrenic and affective disorders.
View details for
View details for